Kommentar
Navigating PSMA PET Radiopharmaceuticals: Clinical and Operational Factors
American Journal of Roentgenology · 01.07.2026
DOI: 10.2214/ajr.26.35482 ↗Kurz gefasst
Kommentar in der Zeitschrift American Journal of Roentgenology, online erschienen am 01.07.2026. Verfasst von Hossein Jadvar. Beteiligte Einrichtung: Departments of Radiology, Radiation Oncology, and Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
CancerPETPSMAProstate
Autor:innen und Institutionen
- Departments of Radiology, Radiation Oncology, and Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
- Departemnt of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA.
Zitieren
APA
Jadvar, H. (2026). Navigating PSMA PET Radiopharmaceuticals: Clinical and Operational Factors. American Journal of Roentgenology. https://doi.org/10.2214/ajr.26.35482
Vancouver
Jadvar H. Navigating PSMA PET Radiopharmaceuticals: Clinical and Operational Factors. American Journal of Roentgenology. 2026. doi:10.2214/ajr.26.35482
BibTeX
@article{Jadvar2026,
author = {Jadvar, Hossein},
title = {Navigating PSMA PET Radiopharmaceuticals: Clinical and Operational Factors},
journal = {American Journal of Roentgenology},
year = {2026},
doi = {10.2214/ajr.26.35482}
}
EUVIMED